Khanu
Venture capitalPre-Seed–Seed
Investment thesis
KHAN focuses on closing the translation gap between academic science and marketable pharmaceutical products, particularly in drug discovery. It partners with the Lead Discovery Center to provide industry-standard drug discovery services and has a strategic co-funding partnership with the Max Planck Society to jointly invest, on a 50:50 basis, in promising early-stage academic drug discovery projects originating from Max Planck Institutes. The firm is backed by institutional partners including the European Investment Fund (via InnovFin Equity and EU/EFSI backing), the Max Planck Foundation, Austria Wirtschaftsservice, and family office Thyssen'sche Handelsgesellschaft.
Source: firm website, verified Aug 7, 2026.
What they invest in
from 3 of 6 portfolio companiesImpact & Social Good ×3Deep Tech ×2Cleantech ×1Climate Tech ×1Energy ×1Enterprise Software ×1Fintech ×1GovTech ×1
HQs:Austria×1Germany×1European Union×1
Investments · 6 tracked
founders shown can be your intro pathThis is a page describing "Industrielle Schlüsseltechnologien – Leitbetriebe 2030," a grant funding program from Austria's aws (Austria Wirtschaftsservice) that provides non-repayable grants of up to 3 million euros for projects in strategic future fields such as AI, advanced production technologies, new materials, energy and environmental technologies, and aviation and mobility.
Deep TechGovTechImpact & Social GoodSaaS
The European Investment Fund is a multilateral development bank with AAA credit ratings that provides capital and financing to foster economic impact through its strong balance sheet and governance.
CleantechClimate TechEnergyEnterprise SoftwareFintechImpact & Social GoodLuxembourg, EU
Co-investorsEIFAlpine Space VenturesBOMCrowberry CapitalInvivo Capital PartnersM80 Partners+3 more
Announced a €4.45 million seed financing to advance its covalent allosteric inhibitor platform addressing unmet medical needs in oncology.
The Max Planck Foundation is a German charitable foundation, established in 2006 by private donors, that channels private funding to basic research at the institutes of the Max Planck Society.
Deep TechImpact & Social Good
Frequently asked questions
- How many investments has Khanu made?
- Khanu has 6 tracked investments.
- What stage does Khanu invest at?
- Khanu invests at the Pre-Seed, Seed stages.
- What sectors does Khanu focus on?
- Khanu focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
- Who does Khanu co-invest with?
- Khanu most often shares deals with Alpine Space Ventures, BOM, Crowberry Capital, among 8 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.